RET-IN-3
RET-IN-3 is a selective kinase inhibitor targeting the RET V804M gatekeeper mutation. It is a research tool for investigating RET-driven oncogenesis, with utility in both in vitro biochemical assays and in vivo models of non-small cell lung cancer (NSCLC) .
Product Specifications
CAS Number
2414374-53-9
Product Name Alternative
CRET, RET IN 3, RETIN3, RET-IN-3, RETV804M
Field of Research
Cell Biology, Signal Transduction
Purity
99.52% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.89 mM) ; DMSO:50 mg/mL (147.32 mM)
Smiles
CN (C) CCCNc1ccn2ncc (-c3ccc4OCOc4c3) c2n1
Molecular Formula
C18H21N5O2
Molecular Weight
339.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YP-W17340-01 48 Tests
Human soluble programmed death Ligand 1 antibody (sPD-L1-Ab) ELISA Kit
Sign In for Pricing
View Details YP-W17340-02 96 Tests
Human soluble programmed death Ligand 1 antibody (sPD-L1-Ab) ELISA Kit
Sign In for Pricing
View Details 
127930J0-AAT 100 Tests
IFluor® 700 Anti-human CD279 Antibody *J116*
Sign In for Pricing
View Details MBS6201850-01 0.1 mL
MS4A15 (Membrane-spanning 4-domains Subfamily A Member 15, FLJ34527, MGC35295) (MaxLight 490)
Sign In for Pricing
View Details